Veru Inc. VERU
NASDAQ VERU
$2.14 +0.02 (+0.94%)
At close: Nov 11, 2026 · 4:00 PM EST

Veru (VERU) Asset Writedowns and Impairment (2018 - 2024)

Updated

Analysis

Veru (VERU) Asset Writedowns and Impairment (2018 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Veru 48.87 Mn -61.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 300,663.00
Mar 31, 2023 3.90 Mn
Sep 30, 2021 408,418.00
Jun 30, 2021 132,572.00
Mar 31, 2021 33,375.00
Dec 31, 2020 9,138.00
Sep 30, 2020 14.10 Mn
Jun 30, 2020 -1,065.00
Mar 31, 2020 77,125.00
Dec 31, 2019 151,922.00
Sep 30, 2019 -3,391.00
Jun 30, 2019 60,574.00
Mar 31, 2019 29,679.00
Dec 31, 2018 22,245.00
API Access

Veru Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VERU&period=max&api_key=YOUR_API_KEY